Vaccitech confidentially files for Nasdaq IPO

Another biotech is reportedly headed to Nasdaq, one that plays a prominent role in the Covid-19 vaccine race.

Coming from the shores of Britain, Vaccitech confidentially filed for an IPO on Wednesday, per a report from the Financial Times.